A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas

Clinical trial NCT00274651 · TERMINATED

Trial details

NCT number: NCT00274651
Sponsor: Valerio Therapeutics
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous T-Cell Lymphoma Peripheral T-Cell Lymphoma Non-Hodgkin's Lymphoma

Start date: 2006-01-01
Primary completion: 2009-07-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.